Clinical Trial Update: Intravesicular Onabotulinumtoxin A in Interstitial Cystitis [Phase 4]

View source ↗

Summary

Phase 4 trial update for intravesicular onabotulinumtoxinA in interstitial cystitis completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Interstitial Cystitis

Drugs mentioned

• Onabotulinumtoxin A (botulinum toxin type A)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Interstitial Cystitis | Phase 4 | Status: COMPLETED | Results posted: 2018-05-22